ForeverLabs
servicesprovidersmission
Schedule a consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Cancer Stem Cells
generated-image-1.jpg
Clinical
Dec 1, 2025
1 min read
Pmc
p53 Switches Off Pluripotency on Differentiation
New findings reveal that the p53 protein is essential for guiding stem cells to differentiate safely, potentially reducing cancer risks. By reactivating p53, researchers could enhance stem cell therapies and develop innovative cancer treatments, paving the way for safer regenerative medicine.
Induced Pluripotent Stem Cells (iPSCs)Cancer Stem CellsStem Cell Differentiation

Stay in touch

Shop

Annual planLifetime PlanClient Login

Learn

ArticlesBlogFAQ

Careers

About usPrivacy PolicyPressTerms of Service

For Clinics

Scheduler LoginFor PhysiciansPartner With UsContact Us
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTube

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.